This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griffiths, J. R. Articles by Stubbs, M. Search for Related Content PubMed PubMed Citation Articles by Griffiths, J. R. Articles by Stubbs, M.

Metabolic Changes Detected by in Vivo Magnetic Resonance Studies of HEPA-1 Wild-Type Tumors and Tumors Deficient in Hypoxia-inducible Factor-1ß (HIF-1ß): Evidence of an Anabolic Role for the HIF-1 Pathway¹

CRC Biomedical Magnetic Resonance Research Group, Department of Biochemistry and Immunology, St. George’s Hospital Medical School, London SW17 0RE [J. R. G., P. M. J. M., S. P. R., H. T., Y-L. C., M. S.]; School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester M13 9PL [K. J. W., I. J. S.]; and Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU [R. D. L., A. L. H.], United Kingdom

Hypoxia-inducible factor-1 (HIF-1) regulates many pathways potentially important for tumor growth, including angiogenesis and glycolysis. Most attention has focused on its role in the response to hypoxia, but HIF-1 is also constitutively expressed in many tumors. To analyze the role of this pathway in vivo, we used magnetic resonance (MR) methods and complementary techniques to monitor metabolic changes in tumors derived from HEPA-1 mouse hepatoma lines that were either wild type (WT) or deficient in hypoxia-inducible transcription factor HIF-1ß (c4). The c4 tumors grew significantly more slowly than the WT tumors (P < 0.05), but were examined at a similar size (0.4–0.6 g). At the tumor size used in these studies, no differences in vascularity were observed, and MR parameters measured that related to tumor blood flow, vascularity, and oxygenation demonstrated no significant differences between the two tumor types. Unexpectedly, the ATP content of the c4 tumor was 5 times less than in the WT tumor [measured in tumor extracts (P < 0.001) and by metabolic imaging (P < 0.05)]. Noninvasive ³¹P MR spectroscopy showed that the nucleoside triphosphate/P_i ratio of the two tumor types was similar, so the low ATP content of the c4 tumors was not caused by (or a cause of) impaired cellular bioenergetics. Rather, glycine, an essential precursor for de novo purine formation, was significantly lower in the c4 tumors (P < 0.05), suggesting that ATP synthesis was impaired in the mutant tumor cells. Supporting evidence for this hypothesis came from the significantly lower concentrations of betaine, phosphocholine, and choline in the c4 tumors (P < 0.05); these are intermediates in an alternative pathway for glycine synthesis. No significant differences were seen in lactate or glucose content. MR resonances from phosphodiesters, which relate to the metabolic turnover of phospholipid membranes, were significantly lower in the WT tumors than in the c4 tumors, both in vivo (P < 0.05) and in extracts (P < 0.01). We propose that loss of up-regulation of expression of the genes for glucose transporters and glycolytic enzymes in the c4 tumors decreased formation of glycine, an essential precursor of ATP synthesis, and thus caused the low ATP content of the c4 tumors. In summary, these data suggest that disruption of the HIF-1 pathway in these tumor cells impairs the supply of anabolic precursors required for cell synthesis. They suggest potential biochemical targets that may be modified by therapy blocking HIF-1 function.

This article has been cited by other articles:

				C. Calabrese, A. Pisi, G. Di Febo, G. Liguori, G. Filippini, M. Cervellera, V. Righi, P. Lucchi, A. Mucci, L. Schenetti, et al. Biochemical Alterations from Normal Mucosa to Gastric Cancer by Ex vivo Magnetic Resonance Spectroscopy Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1386 - 1395. [Abstract] [Full Text] [PDF]

				C. Denkert, J. Budczies, T. Kind, W. Weichert, P. Tablack, J. Sehouli, S. Niesporek, D. Konsgen, M. Dietel, and O. Fiehn Mass Spectrometry-Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors. Cancer Res., November 15, 2006; 66(22): 10795 - 10804. [Abstract] [Full Text] [PDF]

				J. G. Bundy, N. G. Iyer, M. S. Gentile, D.-E. Hu, M. Kettunen, A.-T. Maia, N. P. Thorne, J. D. Brenton, C. Caldas, and K. M. Brindle Metabolic Consequences of p300 Gene Deletion in Human Colon Cancer Cells. Cancer Res., August 1, 2006; 66(15): 7606 - 7614. [Abstract] [Full Text] [PDF]

				L. M. Brown, R. L. Cowen, C. Debray, A. Eustace, J. T. Erler, F. C. D. Sheppard, C. A. Parker, I. J. Stratford, and K. J. Williams Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1 Mol. Pharmacol., February 1, 2006; 69(2): 411 - 418. [Abstract] [Full Text] [PDF]

				A. Vengellur, J. M. Phillips, J. B. Hogenesch, and J. J. LaPres Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells Physiol Genomics, August 11, 2005; 22(3): 308 - 318. [Abstract] [Full Text] [PDF]

				A. M. Arsham, D. R. Plas, C. B. Thompson, and M. C. Simon Akt and Hypoxia-Inducible Factor-1 Independently Enhance Tumor Growth and Angiogenesis Cancer Res., May 15, 2004; 64(10): 3500 - 3507. [Abstract] [Full Text] [PDF]

				G. Hopfl, O. Ogunshola, and M. Gassmann HIFs and tumors--causes and consequences Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R608 - R623. [Abstract] [Full Text] [PDF]

				Y.-L. Chung, H. Troy, U. Banerji, L. E. Jackson, M. I. Walton, M. Stubbs, J. R. Griffiths, I. R. Judson, M. O. Leach, P. Workman, et al. Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Heat Shock Protein 90 Inhibitor 17-Allylamino,17-Demethoxygeldanamycin (17AAG) in Human Colon Cancer Models J Natl Cancer Inst, November 5, 2003; 95(21): 1624 - 1633. [Abstract] [Full Text] [PDF]

				J. S. Isaacs, Y.-J. Jung, E. G. Mimnaugh, A. Martinez, F. Cuttitta, and L. M. Neckers Hsp90 Regulates a von Hippel Lindau-independent Hypoxia-inducible Factor-1alpha -degradative Pathway J. Biol. Chem., August 9, 2002; 277(33): 29936 - 29944. [Abstract] [Full Text] [PDF]